Acadian Asset Management LLC Lumos Pharma, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$7.36 - $11.36 $16,088 - $24,832	-2,186 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$9.75 - $13.44 $36,006 - $49,633	-3,693 Reduced 62.82%	2,186 $22,000
Q1 2021 May 11, 2021	BUY	$11.58 - $31.11 $26,807 - $72,019	2,315 Added 64.96%	5,879 $69,000
Q4 2020 Feb 11, 2021	SELL	$13.61 - $35.91 $21,735 - $57,348	-1,597 Reduced 30.94%	3,564 $127,000
Q3 2020 Nov 09, 2020	SELL	$13.25 - $16.5 $409,213 - $509,586	-30,884 Reduced 85.68%	5,161 $71,000
Q2 2020 Aug 12, 2020	BUY	$7.76 - $16.99 $279,709 - $612,404	36,045 New	36,045 $594,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.